LEVERNA Trademark

Trademark Overview


On Friday, May 27, 2022, a trademark application was filed for LEVERNA with the United States Patent and Trademark Office. The USPTO has given the LEVERNA trademark a serial number of 97432424. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, August 27, 2024. This trademark is owned by Fosun Pharma USA Inc.. The LEVERNA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biochemical research and development; Biotechnology research; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of RNA-targeted drugs; Research and development in the field of nucleic acids, biologics, central nervous system diseases, metabolic diseases, and small molecule drugs; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
leverna

General Information


Serial Number97432424
Word MarkLEVERNA
Filing DateFriday, May 27, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, August 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements


Goods and ServicesBiochemical research and development; Biotechnology research; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of RNA-targeted drugs; Research and development in the field of nucleic acids, biologics, central nervous system diseases, metabolic diseases, and small molecule drugs; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 3, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFosun Pharma USA Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Party NameFosun Pharma USA Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Trademark Events


Event DateEvent Description
Tuesday, May 31, 2022NEW APPLICATION ENTERED
Friday, June 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 5, 2022ASSIGNED TO EXAMINER
Monday, December 5, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 7, 2023SOU EXTENSION 1 FILED
Monday, October 9, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 10, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, October 10, 2023TEAS PETITION TO REVIVE RECEIVED
Tuesday, October 10, 2023PETITION TO REVIVE-GRANTED
Tuesday, October 10, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, October 10, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, October 10, 2023NOTICE OF REVIVAL - E-MAILED
Monday, October 23, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 26, 2023SOU EXTENSION 1 GRANTED
Friday, October 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 5, 2024SOU TEAS EXTENSION RECEIVED
Monday, February 5, 2024SOU EXTENSION 2 FILED
Monday, February 5, 2024SOU EXTENSION 2 GRANTED
Wednesday, February 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 27, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 27, 2024SOU EXTENSION 3 FILED
Tuesday, August 27, 2024SOU EXTENSION 3 GRANTED